Jukes TH, Hill DC, Branion HD. Effect of feeding antibiotics on the intestinal track of the chicks. Poultry Sci. 1956; 35: 716–723.
Angulo FJ, Tauxe RV, Cohen ML. The origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for use of fluoroquinolones in food animals. In Use of Quinolones in Food animals and Potential Impact on Human Health. WHO/EMC/ZDI/98.10 Geneva. Switzerland: World Health Organization; June 2–5, 1998: 205–219.
Cohen ML, Tauxe RV. Drug-resistant Salmonella in the United States: An epidemiologic perspective. Science. 1986; 234: 964–969.PubMedCrossRef
Holmberg SD, Osterholm MT, Senger KA, Cohen ML. Drug-resistant Salmonella from animals fed antimicrobials. N Engl J Med. 1984; 311(10): 617–622.PubMed
Spika JS, Waterman SH, Hoo GW, et al. Chloramphenicol-resistant Salmonella Newport traced through hamburger to dairy farms. N Engl J Med. 1987; 316(10): 565–570.PubMed
Tacket CO, Dominguez LB, Fisher HJ, Cohen ML. An outbreak of multiple-drug-resistant Salmonella enteritis from raw milk. JAMA 1985; 253(14): 2058–2060.PubMedCrossRef
Van den Bogaard AE, London N, Driessen C, Stobberingh EE. Antibiotic resistance of faecal Escherichia coli in poultry, poultry famers and poultry slaughterers. J Antimicrob Chemother. 2001; 47: 763–771.PubMedCrossRef
White DG, Zhao S, Sudler R, et al. The isolation of antibiotic-resistant Salmonella from retail ground meats. N Engl J Med. 2001; 345(16): 1147–1154.PubMedCrossRef
Edgar R, Bibi E. MdfA and Escherichia coli multidrug resistance protein with extraordinarily broad spectrum of drug recognition. J Bacteriol. 1997; 179: 2274–2280.PubMed
Leclercq, R, Courvalin P. Bacterial resistance to the macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother. 1991; 35: 1267–1272.PubMed
UK Joint Committee of Houses of Parliament. Report on the Use of Antibiotics, in Animal Husbandry and Veterinary Medicine (“Swann Report”). London, UK: Her Majesty's Stationery Office; 1969.
Institute of Medicine. Committee on Human Health Risk Assessment of Using Subtherapeutic Antibiotics in Animal Feeds. Human health risks with the subtherapeutic use of penicillin or tetracyclines in animal feed. Washington, DC: National Academy Press; 1989.
American Society for Microbiology. Report of the American Society for Microbiology Task Force on Antibiotic Resistance. Washington, DC: The American Society for Microbiology, Public and Scientific Affairs Board; March 16, 1995.
Crom R, Stohr K. Results of the WHO meeting on the medical impact of the use of antimicrobials in food animals. In: The Role of Veterinary Therapeutics in Bacterial Resistance Development: Animal and Public Health Perspectives, Proceedings, January 19–21, 1998. College Park, MD: University of Maryland Press; 1998: 94–100.
World Health Organization. The medical impact of the use of antimicrobials in food animals WHO/EMC/ZOO/97.4. Berlin, Germany: October 13–17, 1997.
World Health Organization. Use of quinclones in food animals and potential impact on human health. WHO/EMC/ZDI/98.10. Geneva. Switzerland; June 2–5, 1998.
European Commission. Opinion of the Scientific Steering Committee on Antimicrobial Resistance. European Commission Directorate General XXIV. Consumer Policy and Consumer Health Protection. Brussels, Belgium: European Commission; May 28, 1999.
Australia Commonwealth Department of Agriculture, Fisheries and Forestry. The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. Report of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR), 1999. Available at http://www.health.gov.au/pubhlth/publicat/document/metadata/jetacar.htm.
Australia Commonwealth Department of Agriculture, Fisheries and Forestry. The Commonwealth Govemment Response to the Report of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR), August 2000. Available at http://www.health.gov.au/pubhlth/publicat/document/metadata/jetacar.htm.
World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. WHO/CDS/CSR/DRS/2001.21. Geneva. Switzerland; 2001.
Friedlander LG, Brynes SD, Femandez AH. The human food safety evaluation of new animal drugs. In: Tollefson L, ed. Chemical Food Bome Hazards and Their Control, Veterinary Clinics of North America. Food Animal Practice. 1999;15(1):1–11.
Paige JC, Tollefson L, Miller M. Public health impact of drug residues in animal tissues. Vet Hum Toxicol. 1997; 39(3): 162–169.PubMed
US Food and Drug Administration. Guidance for Industry: Consideration of the human health impact of the microbial effects of antimicrobial new animal drugs intended for use in food-producing animals (GFI #78). Federal Register. 1999; 64: 72083. Available at http://www.fda.gov/cvm/guidance/guidad78.html.
Department of Health and Human Services. Public Health Action Plan to Combat Antimicrobial Resistance. January 2001. Available at http://www.cdc.gov/drugresistance/actionplan/.
US Food and Drug Administration. A proposed framework for evaluating and assuring the human safety of the microbial effects of antimicrobial new animal drugs intended for use in food-producing animals. Federal Register. 1999; 64: 887, Available at http://www.fda.gov/cvm/index/vmac/antimi18.htm.
Tollefson L, Angulo FJ, Fedorka-Cray PJ. National surveillance for antibiotic resistance in zoonotic enteric pathogens. In: Tollefson L. ed. Microbial Food Bome Pathogens. Veterinary Clinics of North America: Food Animal Practice. 1998;14(1):141–150.
US Food and Drug Administration. An approach for establishing thresholds in association with the use of antimicrobial drugs in food-producing animals. Federal Register 2000; 65: 830700. Available at http://www.fda.gov/cvm/antimicrobial/threshold21.doc.